Augmentation of Pharmacotherapy by Sleep Deprivation with Sleep Phase Advance in Treatment-Resistant Depression

被引:12
|
作者
Kurczewska, Ewa [1 ]
Ferensztajn-Rochowiak, Ewa [1 ]
Jasinska-Mikolajczyk, Anna [1 ]
Chlopocka-Wozniak, Maria [1 ]
Rybakowski, Janusz K. [1 ]
机构
[1] Poznan Univ Med Sci, Dept Adult Psychiat, Szpitalna 27-33, PL-60572 Poznan, Poland
关键词
treatment-resistant depression; total sleep deprivation; sleep phase advance; allostatic load; COGNITIVE-BEHAVIORAL THERAPY; LIGHT THERAPY; ANTIDEPRESSANT RESPONSE; BIPOLAR DEPRESSION; REMISSION; CYTOKINES; LITHIUM; IMPACT; CHRONOTHERAPEUTICS; NEUROENDOCRINE;
D O I
10.1055/a-0695-9138
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction The aim was to assess the efficacy of total sleep deprivation (TSD) with sleep phase advance (SPA) in treatment-resistant depression (TRD) and associated biochemical factors. Methods We studied nine males and 12 females, aged 4914 years, with treatment-resistant unipolar or bipolar depression, receiving antidepressant and mood-stabilizing drugs. The four-day schedule included single TSD and three consecutive nights with SPA. Biochemical markers were measured on the day before and on 1st, 7th and 14th day after the TSD. Results Ten subjects met criteria for response, defined as a reduction of >= 50% in the Hamilton Depression Rating Scale, on the 14th day. Concentrations of cortisol at baseline were lower in responders, and they decreased during therapy in both groups. In responders, there was an increase of interleukin-10 (IL-10) and IL-1 beta on the 14th day. Discussion Our preliminary study demonstrated the efficacy of pharmacotherapy augmentation by TSD and SPA in half of the patients with TRD. The main biochemical factors related to clinical response included status of cortisol and increase in IL-10 and IL-1 beta levels.
引用
收藏
页码:186 / 192
页数:7
相关论文
共 50 条
  • [41] Sleep deprivation followed by sleep phase advance therapy to stabilize the positive sleep-deprivation effect in depressive episodes
    Albert, R
    Merz, A
    Schubert, J
    Ebert, D
    NERVENARZT, 1998, 69 (01): : 66 - 69
  • [42] SLEEP-DEPRIVATION WITH CONSECUTIVE SLEEP-PHASE ADVANCE THERAPY IN PATIENTS WITH MAJOR DEPRESSION - A PILOT-STUDY
    VOLLMANN, J
    BERGER, M
    BIOLOGICAL PSYCHIATRY, 1993, 33 (01) : 54 - 57
  • [43] Total sleep deprivation followed by sleep phase advance and bright light therapy in drug-resistant mood disorders
    Echizenya, Masaru
    Suda, Hideka
    Takeshima, Masahiro
    Inomata, Yoshiyuki
    Shimizu, Tetsuo
    JOURNAL OF AFFECTIVE DISORDERS, 2013, 144 (1-2) : 28 - 33
  • [44] Sleep architecture parameters as a putative biomarker of suicidal ideation in treatment-resistant depression
    Bernert, Rebecca A.
    Luckenbaugh, David A.
    Duncan, Wallace C.
    Iwata, Naomi G.
    Ballard, Elizabeth D.
    Zarate, Carlos A.
    JOURNAL OF AFFECTIVE DISORDERS, 2017, 208 : 309 - 315
  • [45] Amantadine as augmentation therapy in the management of treatment-resistant depression
    Stryjer, R
    Strous, RD
    Shaked, G
    Bar, F
    Feldman, B
    Kotler, M
    Polak, L
    Rosenzcwaig, S
    Weizman, A
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2003, 18 (02) : 93 - 96
  • [46] Paliperidone Augmentation for Treatment-Resistant Depression A Case Report
    Yang, Fei-Wen
    Liang, Chih-Sung
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 31 (02) : 245 - 246
  • [47] Quetiapine augmentation of treatment-resistant depression:: a comparison with lithium
    Doree, Jean-Pierre
    Rosiers, Joel Des
    Lew, Viviane
    Gendron, Alain
    Elie, Robert
    Stip, Emmanuel
    Tourjman, S. Valerie
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (02) : 333 - 341
  • [48] Aripiprazole Augmentation in Older Persons with Treatment-Resistant Depression
    Lewis, Gemma
    Lewis, Glyn
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (12): : 1137 - 1138
  • [49] LITHIUM AUGMENTATION OF VALPROIC ACID IN TREATMENT-RESISTANT DEPRESSION
    SHARMA, V
    PERSAD, E
    KUENEMAN, K
    MAZMANIAN, D
    WADDEN, P
    LITHIUM, 1994, 5 (02): : 99 - 103
  • [50] Lamotrigine augmentation strategy for patients with treatment-resistant depression
    Gutierrez, RL
    McKercher, R
    Galea, J
    Jamison, KL
    CNS SPECTRUMS, 2005, 10 (10) : 800 - +